Subclinical hyperthyroidism when presenting as initial manifestation of juvenile Hashimoto's thyroiditis: first

Insights

Pediatric subclinical hyperthyroidism (SH) due to Hashimoto's thyroiditis (HT) often resolves within 24 months. Some children may develop hypothyroidism or Graves' disease, suggesting SH and overt hyperthyroidism (Htx) may be stages of the same condition.

Area of Science:

  • Pediatric Endocrinology
  • Thyroidology
  • Autoimmune Diseases

Background:

  • Limited data exist on the natural history of endogenous subclinical hyperthyroidism (SH) in children.
  • Hashimoto's thyroiditis (HT) is a common cause of thyroid dysfunction in pediatric populations.

Purpose of the Study:

  • To investigate the natural history of SH as an initial manifestation of HT in children.
  • To compare the spontaneous evolution of HT-related SH with HT-related frank hyperthyroidism (Hashitoxicosis, Htx) in age-matched pediatric patients.

Main Methods:

  • Retrospective analysis of two groups of children with HT.
  • Group A: presented with SH (suppressed TSH, normal FT4).
  • Group B: presented with Htx (suppressed TSH, elevated FT4).
  • Follow-up assessment of thyroid function and antibody levels.

Main Results:

  • TSH normalization occurred spontaneously within 1-24 months in the SH group and 3-9 months in the Htx group.
  • In the SH group, the time to normalization correlated with baseline thyroid peroxidase antibodies.
  • During follow-up, most patients remained euthyroid, but some developed hypothyroidism or Graves' disease.

Conclusions:

  • Hashimoto's thyroiditis should be recognized as a cause of endogenous SH in children.
  • Spontaneous TSH normalization in pediatric HT-related SH occurs within 24 months, similar to Htx.
  • Deterioration of thyroid function can occur during follow-up in both conditions, suggesting they may represent stages of a continuum.
Abstract

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32